Cell MedX

Cell MedX Corp is an early development stage company focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.In April 2020, the company announced a non-brokered private placement offering at a price of $0.25 per Unit for up to 1,000,000 Units for total gross proceeds of $250,000. Each warrant consists of one share of the company's common stock at $0.35 per share during the first six month from the date of closing of the offering, and at $0.50 per share during the remaining life of the warrant.In June 2019, the company closed the first tranche of its non-brokered private placement offering at a price of $0.12 per unit by issuing 3,950,000 units for total gross proceeds of $474,000. Each unit consisted of one common share of the company and one share purchase warrant entitling the holder to purchase one additional common share for a period of two y